Home LiteratureArticle Details
PMID: 429301 Published · ppublish English Journal Article

A novel method of activation of cross-linked agaroses with 1,1'-carbonyldiimidazole which gives a matrix for affinity chromatography devoid of additional charged groups.

The Journal of biological chemistry ·Vol. 254 ·No. 8 ·1979-04-25 ·Pages 2572-4

Bethell GS, Ayers JS, Hancock WS, Hearn MT

Abstract

1,1'-Carbonyldiimidazole, a carbonylating reagent, has been shown to be suitable for the activation of cross-linked agaroses for affinity chromatography. The activated matrix (an imidazolyl carbamate) is relatively stable to hydrolysis but smoothly reacts with N-nucleophiles such as those present in either affinity chromatography ligands or leashes, e.g. ethylenediamine or 6-aminohexanoic acid. If butylamine was attached via the 1,1'-carbonyldiimidazole method, the resulting product was devoid of charged groups and thus had the same titration curve as agarose. The suitability of this new matrix for affinity chromatography was demonstrated by the successful purification of trypsin by several different systems.

MeSH Terms
Chemical Phenomena Chemistry Chromatography, Affinity/methods Imidazoles Polysaccharides Sepharose Trypsin/isolation & purification Trypsin Inhibitors
Chemicals
Imidazoles Polysaccharides Trypsin Inhibitors Sepharose Trypsin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bethell G S
Ayers J S
Hancock W S
Hearn M T
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1979-04-25
Pages
2572-4
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]